In July 2022, the Consultation Document on Proposed New Risk Management Actions for 2-Butanone, oxime was published for a public comment period, ending on October 13, 2022. The purpose of this ...
a This substance was not identified under subsection 73(1) of CEPA but was included in this assessment as it was considered a priority on the basis of other human health concerns. All ten substances ...